false
0001674227
0001674227
2026-07-24
2026-07-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 24, 2026
SCWorx Corp.
(Exact name of registrant as specified in its
charter)
| Delaware |
|
001-37899 |
|
47-5412331 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
35 Village Road, Suite 100
Middleton, MA 01949
(Address of principal executive offices and
zip code)
Registrant’s telephone number, including
area code: (844) 472-9679
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| N/A |
|
N/A |
|
N/A |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
By
letter dated July 24, 2026, Nasdaq notified the Company that the Company’s Market Value of Publicly Held Shares (“MVPHS”)
did not maintain the minimum MVPHS of $1 million during the last 30 consecutive business days (June 10, 2026 to July 23, 2026), as required
by Nasdaq Listing Rule 5550(a)(5). Consequently, the Company no longer meets the listed securities requirement to maintain minimum MVPHS
of $1,000,000 pursuant to Nasdaq Rules 5550(a)(5) .
The
Nasdaq Rules provide a compliance period of 180 calendar days, through January 20, 2027, in which to regain compliance.
Under
the Nasdaq Rules, if at any time during this 180-day compliance period the MVPHS of the Company’s securities is at least $1,000,000
for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance, and the matter would be closed.
However, Nasdaq has the discretion to require the Company to satisfy the MVPHS requirement for a period in excess of ten consecutive business
days, but generally no more than twenty consecutive business days, before determining that the company has demonstrated an ability to
maintain long term compliance. The Company is reviewing the Nasdaq Deficiency Notice and evaluating the alternatives that may be available
to it to regain and thereafter sustain compliance with the MVPHS Requirement and with all other applicable Nasdaq continued listing requirements.
As of the date of this Current Report, the Company’s board of directors has not determined which alternative or combination of alternatives,
if any, it will pursue. There can be no assurance that the Company will regain compliance with the MVPHS Requirement, or that the Company’s
securities will remain listed on Nasdaq.
In
the event that the Company does not regain compliance during the 180-day compliance period, Nasdaq will provide written notification to
the Company that its Common Stock is subject to delisting. At that time, the Company may appeal the relevant delisting determination to
a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that,
if the Company does appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
SCWorx Corp. |
| |
|
| |
By: |
/s/ Timothy Hannibal |
| |
|
Timothy Hannibal |
| |
|
CEO |
| |
|
|
| Dated: July 28, 2026 |
|
|